Aelis Farma Balance Sheet Health

Financial Health criteria checks 6/6

Aelis Farma has a total shareholder equity of €9.9M and total debt of €3.9M, which brings its debt-to-equity ratio to 39.4%. Its total assets and total liabilities are €20.5M and €10.5M respectively.

Key information

39.4%

Debt to equity ratio

€3.92m

Debt

Interest coverage ration/a
Cash€12.59m
Equity€9.94m
Total liabilities€10.53m
Total assets€20.47m

Recent financial health updates

No updates

Recent updates

Take Care Before Jumping Onto Aelis Farma SA (EPA:AELIS) Even Though It's 29% Cheaper

Oct 21
Take Care Before Jumping Onto Aelis Farma SA (EPA:AELIS) Even Though It's 29% Cheaper

Aelis Farma SA's (EPA:AELIS) 49% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Sep 06
Aelis Farma SA's (EPA:AELIS) 49% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Some Confidence Is Lacking In Aelis Farma SA (EPA:AELIS) As Shares Slide 49%

Sep 06
Some Confidence Is Lacking In Aelis Farma SA (EPA:AELIS) As Shares Slide 49%

Financial Position Analysis

Short Term Liabilities: AELIS's short term assets (€18.8M) exceed its short term liabilities (€6.3M).

Long Term Liabilities: AELIS's short term assets (€18.8M) exceed its long term liabilities (€4.2M).


Debt to Equity History and Analysis

Debt Level: AELIS has more cash than its total debt.

Reducing Debt: AELIS's debt to equity ratio has reduced from 169.1% to 39.4% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: AELIS has sufficient cash runway for 11 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: AELIS is forecast to have sufficient cash runway for 11 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies